MPT0B014 – 5 mg

Brand:
Cayman
CAS:
1215208-59-5
Storage:
-20
UN-No:
- 2811 / 6.1

MPT0B014 is an inhibitor of tubulin polymerization.{53719} It inhibits proliferation of A549, H1299, and H226 human non-small cell lung cancer (NSCLC) cells (IC50s = 0.041, 0.046, and 0.041 µM, respectively), as well as adriamycin-resistant NCI/ADR cells that overexpress P-glycoprotein (IC50 = ~0.03 µM). MPT0B014 (0.3 µM) induces cell cycle arrest at the G2/M phase and apoptosis in A549 cells. It reduces tumor growth in an A549 mouse xenograft model when administered in combination with the EGFR tyrosine kinase inhibitor erlotinib (Item No. 10483).  

 

Out of stock

SKU: 21718 - Category:

Description

A tubulin polymerization inhibitor; inhibits proliferation of A549, H1299, and H226 human NSCLC cells (IC50s = 0.041, 0.046, and 0.041 µM, respectively), as well as adriamycin-resistant NCI/ADR cells that overexpress P-glycoprotein (IC50 = ~0.03 µM); induces cell cycle arrest at the G2/M phase and apoptosis in A549 cells at 0.3 µM; reduces tumor growth in an A549 mouse xenograft model when administered in combination with erlotinib


Formal name: 6-quinolinyl(3,4,5-trimethoxyphenyl)methanone

Synonyms: 

Molecular weight: 323.3

CAS: 1215208-59-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Microtubule Dynamics||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Multidrug Resistance||Research Area|Cell Biology|Cytoskeleton & Motor Proteins